Certara Stock News
$11.48
2.63%
day before yesterday
Nasdaq,
Sep 19, 10:04 pm CET
Index
Industry
Certara Stock News
Neutral
Seeking Alpha
●
11 days ago
Certara, Inc. (NASDAQ:CERT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 12:20 PM EDT Company Participants John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. I think we're on time here.
Neutral
Seeking Alpha
●
12 days ago
Certara, Inc. (NASDAQ:CERT ) Baird Global Healthcare Conference 2025 September 9, 2025 10:15 AM EDT Company Participants William Feehery - CEO & Director John Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer Conference Call Participants Joseph Vruwink - Robert W. Baird & Co. Incorporated, Research Division Presentation Joseph Vruwink Senior Research Analyst All right.
Neutral
GlobeNewsWire
●
17 days ago
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the availability of Pinnacle 21 Enterprise Plus.
Neutral
GlobeNewsWire
●
19 days ago
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Neutral
Seeking Alpha
●
27 days ago
Cerrado Gold Inc. (OTCQX:CRDOF) Q2 2025 Earnings Conference Call August 25, 2025 11:00 AM ET Company Participants Michael McAllister - Vice President of Investor Relations Mark Peter Brennan - CEO & Chairman Jason Brooks - Chief Financial Officer Conference Call Participants Operator Thank you for standing by. This is the conference operator.
Neutral
Seeking Alpha
●
about 2 months ago
Certara, Inc. (NASDAQ:CERT ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants John E. Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer William F.
Positive
The Motley Fool
●
about 2 months ago
Certara (CERT -3.35%), a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue beat, with reported GAAP revenue of $104.6 million, exceeding analyst expectations, but non-GAAP earnings per share (EPS) missed consensus by $0.03.
Neutral
GlobeNewsWire
●
about 2 months ago
RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
